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Abstract
Effective physician workforce management requires that the various organizations comprising the House of Medicine be able to
assess their current and future workforce supply. This information has direct relevance to funding of graduate medical education.
We describe a dynamic modeling tool that examines how individual factors and practice variables can be used to measure and
forecast the supply and demand for existing and new physician services. The system we describe, while built to analyze the
pathologist workforce, is sufficiently broad and robust for use in any medical specialty. Our design provides a computer-based
software model populated with data from surveys and best estimates by specialty experts about current and new activities in the
scope of practice. The model describes the steps needed and data required for analysis of supply and demand. Our modeling tool
allows educators and policy makers, in addition to physician specialty organizations, to assess how various factors may affect
demand (and supply) of current and emerging services. Examples of factors evaluated include types of professional services
(3 categories with 16 subcategories), service locations, elements related to the Patient Protection and Affordable Care Act, new
technologies, aging population, and changing roles in capitated, value-based, and team-based systems of care. The model also helps
identify where physicians in a given specialty will likely need to assume new roles, develop new expertise, and become more
efficient in practice to accommodate new value-based payment models.
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Introduction
A thorough understanding of physician workforce supply and
demand is requisite for effectively managing and planning a
nation’s health care. In the United States and elsewhere, phy-
sician workforce trajectories across specialties and subspecial-
ties have been forecast at national and state levels (Table 1).
Some analyses are elaborate, such as ‘‘The Complexities of
Physician Supply and Demand: Projections Through 2025’’
published in 20083 and revised in 2015, 13 while others provide
only baseline estimates, plotting one or a few scenarios.
These studies may be useful at a high level for policy makers
but in general incompletely address important issues at the
specialty level where decisions must be made about how to
implement change and allocate resources to manage the
changes. Identified deficiencies are:
1. Availability of modeling tools for medical specialty use:
Most studies on workforce which survey a state or
nation emanate from stakeholders such as state or
national agencies of health (eg, the US Department of
Health and Human Services, the Dutch Department of
Health, Welfare and Sport, etc), industry associations
(eg, Association of American Medical Colleges
[AAMC], American Society of Clinical Oncology, etc)
and universities (eg, University of Missouri, State Uni-
versity of New York at Albany, University of Tokyo,
etc). These organizations gather information used to
develop estimates by other agencies (physician associa-
tions, eg, American Medical Association [AMA], US
Census Bureau, US Centers for Diseases Control, etc),
and these estimates then form the basis for reports and
board modeling. The physician organizations depend on
these published reports, but the lack of granularity hin-
ders the groups from proactively managing their own
future workforce. Rarely are the individual physician
organizations able to utilize the published studies to plot
their own scenarios for types of future demand, which is
important because the individual associations are often
the most aligned to the market dynamics that impact
their specialty.
2. Effort analytics of workforce supply and demand: Most
models report physician supply and demand in aggre-
gate. Few dig deeper to understand how physicians allo-
cate their time. With the emergence of value-based care
and payment models such as Accountable Care Orga-
nizations, physician organizations have an immediate
need to understand what their providers do and their
beneficiaries receive. Physicians wear multiple hats
(care provider, educator, administrator, investigator,
etc). We believe there is a critical and underserved need
for physician workforce models that permit assessments
at such granular levels.
3. Ability to test multiple scenarios and alter ‘‘what if’’
conditions and variables: Most workforce studies incor-
porate only a limited set of scenarios, rarely more than
5. These scenarios are defined prior to conducting the
analysis so do not incorporate information about new
models of practice collected from the field. This limits
the relevance of the modeling to our rapidly changing
health care environment. These models also lack flexi-
bility where the user can identify and alter single vari-
ables to determine levels of demand or gaps between
supply and demand.
The scenario-based workforce analysis tool we present is an
interactive model that permits the user the ability to incorporate
a wide range of user-defined parameters for modeling future
needs and scenarios, and the ability to adapt the model to new
information such as expanded scope of practice or clinical care
scenarios. We have reported supply11 and demand24 for the
specialty of pathology using this model. This report describes
the interactive model itself and its methodological origins.
Methods
Introduction to the Scenario-Based Workforce
Analysis Tool
Our tool’s origin lies in the multiyear transformation initiative
(called the Case-for-Change, now known as ‘‘Capability and
Society Advancement’’) undertaken by the College of Amer-
ican Pathologists (CAP, or College).25 The initiative focused
on developing an in-depth understanding of the current work-
force and its practice models, identifying new and emerging
market forces (political, economic, commercial, and technol-
ogy related), and ascertaining and measuring the impact these
forces have on the workforce and pathology practice models.
The goal was to identify existing and new services as well as
emerging technologies in which pathologists might play criti-
cal roles in the future.
Scenarios. A scenario refers to independent variables (such as
change in residency slots for a specialty or adoption rate for a
new technology) that affect the numbers of a dependent popu-
lation (for example, supply or demand of healthcare profes-
sional in that specialty), frequently defined in futuristic
sense. Scenario analysis permits charting various paths that
independent variables can take and their consequent impact
on the dependent variables. While scenario analysis does not
reduce the level of uncertainty associated with the market
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Table 1. Illustrative List of Studies Conducted on Physician Workforce.
Authors Study Year Geography & State Study Name Organization Scenarios
United States
Erikson et al1 2007 United States Future Supply and Demand for
Oncologists: Challenges to
Assuring Access to Oncology
Services (forecast until 2020)
ASCO Multiple scenarios (9)
HRSA and
The Lewin
Group2
2008 United States The Physician Workforce:
Projections and Research into
Current Issues Affecting Supply and
Demand
Health Resources & Svc
Admin, US DHHS
Multiple scenarios (8)
Dill and
Salsberg3
2008 United States The Complexities of Physician Supply
and Demand: Projections Through
2025
Center for Workforce
Studies, AAMC
Multiple scenarios
(>12)
Colwill et al4 2008 United States Will Generalist Physician Supply Meet
Demands Of An Increasing And
Aging Population?
U Missouri–Columbia Multiple scenarios (4)
Forte and
Armtrong5
2009 New York New York Physician Supply and
Demand through 2030
The Center for
Healthcare Workforce
Studies, School of
Public Health, U Albany
Multiple scenarios (8)
Staiger et al6 2009 United States Comparison of Physician Workforce
Estimates and Supply Projections
Grant from National
Institute on Aging
Multiple scenarios (4)
Cribbs7 2010 Virginia Physician Forecasting in Virginia
2008 - 2030
Healthcare Workforce
Data Center, Virginia
Dept Health
Professions
Multiple scenarios
Petterson
et al8
2012 United States Projecting US Primary Care Physician
Workforce Needs: 2010-2025
Agency for Healthcare
Research and Quality
Multiple scenarios (3)
Withy et al9 2012 Hawaii Hawai’i Physician Workforce
Assessment 2010
U Hawai’i, HIS Global
Insight
Multiple scenarios (3)
Dall et al10 2013 United States Supply and demand analysis of the
current and future US neurology
workforce
IHS Healthcare & Pharma;
American Academy of
Neurology and others
Multiple scenarios (6)
Robboy
et al11
2013 United States Pathologist workforce in the United
States: I. Development of a
predictive model to examine
factors influencing supply
College of American
Pathologists
Base case only
Fraher12 2014 United States Model for US physician workforce:
Need date
University of North
Carolina at Chapel Hill
Multiple scenarios
Dall et al13 2015 United States The Complexities of Physician Supply
and Demand: Projections Through
2025
Center for Workforce
Studies, AAMC
Multiple scenarios
(>12)
Worldwide
Basu and
Gupta14
2005 Canada A physician demand and supply
forecast model for Nova Scotia
Ministe`re de la Sante´,
Canada
Multiple scenarios
Scheffler
et al15
2008 Global Forecasting the global shortage of
physicians: an economic- and
needs-based approach
U California, Berkeley,
CA, WHO, London
Business School
Multiple scenarios (3)
Koike et al16 2009 Japan Estimation of physician supply by
specialty and the distribution
impact of increasing female
physicians in Japan
Health and Labour
Sciences Research
Grants
Base case only
Barber and
Lopez-
Valcarcel17
2010 Spain Forecasting the need for medical
specialists in Spain: application of a
system dynamics model
U Las Palmas de Gran
Canaria, Campus
Universitario de Tafira
Multiple scenarios
Yuji et al18 2012 Japan Forecasting Japan’s Physician
Shortage in 2035 as the First Full-
Fledged Aged Society
U Tokyo Base case only
(continued)
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forces, it allows stakeholders to better assess the effects of the
most and least likely future events.
New services. The practice of pathology (and many other spe-
cialties) is evolving due to changes brought about by dynamic
market forces, changing practice models, and new technolo-
gies. In pathology, there is growing demand for new services
(eg, genetic testing, in vivo microscopy, and clinical infor-
matics) not associated with the traditional role or expertise of
most practicing pathologists.
Supply Model Section
Our inventory-based model of supply rests on full-time equiv-
alent (FTE) values where actual physician numbers are con-
verted into FTEs based on the average hours in a week that a
particular type of physician works. The model estimates work-
force by determining the current supply and then adds or sub-
tracts net annual increases or decreases, respectively. The
model also partially incorporates complementary workforces
(pathologist assistants [PAs] and PhDs working in the labora-
tory). The key determinants are:
1. Current Supply (Base Year): The modeling process
starts by calculating the pool of active pathologists,
stratified by age and gender. It includes all actively
practicing pathologists, whether board certified or not,
across all practice settings (ie, hospital-based labora-
tories, independent laboratories, research, academia,
industry, etc). The definition of ‘‘active’’ excludes
pathologists who have retired or are trainees in resi-
dency or fellowship programs. These data largely come
from the AMA Masterfile or specialty associations. A
key challenge in this step includes ascertaining the
accurate count of pathologists who are board certified
and estimation of those who are not. Also, we needed to
understand what portion of the pathologist workforce is
composed of board-certified clinicians, typically hema-
tologists and internists, who are certified by their
respective clinical Boards but not by the American
Board of Pathology. Comparison of state registration
declarations against the specialty boards’ records usu-
ally resolves this issue. In our model, we treated inter-
nists who were also board certified by the American
Board of Pathology as if they were full-time patholo-
gists, even though we were unable to determine what
percentage of their efforts might be devoted to truly
clinical practices.11,24 Slightly differently, we treated
only dermatopathologists who were also board certified
in general pathology by the American Board of Pathol-
ogy as full-time pathologists, as many dermatologists
who take their dermatopathology boards continue to
devote substantial efforts to their clinical practices or
examine specimens largely from their own practices.
2. Additions to Workforce: This step aims at estimating
annual net addition to workforce. ‘‘Net additions’’
include trainees who completed their residency or fel-
lowship in the United States or abroad and subsequently
enter the practice of pathology in the United States.
Medical school graduates entering residency include
those from US allopathic medical schools, osteopathic
medical schools, and international medical schools.
These data came from the Accreditation Council for
Graduate Medical Education and the National Resident
Matching Program. Important considerations included
determination of (1) trainees joining the workforce (net
of dropouts and those seeking additional training) and
(2) current gender composition.
3. Separations from the workforce: Separation results
largely from retirement and mortality. Less common
Table 1. (continued)
Authors Study Year Geography & State Study Name Organization Scenarios
Tsai et al19 2012 Global Predicting the demand of physician
workforce: an international model
based on ‘‘crowd behaviors’’
Grant from Health
Department, Executive
Yuan, Taiwan, ROC
Base case only
Health
Workforce
Australia20
2012 Australia Health Workforce 2025—Doctors,
Nurses and Midwives—Volume 1
Health Workforce
Australia
Multiple scenarios
(>10)
de Graaf-
Ruizendaal
and de
Bakker21
2013 Netherlands Construction of decision tool to
analyze local demand and local
supply for GP care using a synthetic
estimation model
Dept Health, Welfare and
Sport in the
Netherlands
Base case only
Suphanchaimat
et al22
2013 Thailand Projecting Thailand physician supplies
between 2012 and 2030:
application of cohort approaches
Ministry of Public Health Base case only
Santric-Milicevic
et al23
2013 Serbia Physician and nurse supply in Serbia
using time-series data
U Belgrade Base case only
Abbreviations: AAMC, Association of American Medical Colleges; ASCO, American Society of Clinical Oncology; US DHHS, US Department of Health and
Human Services; WHO, World Health Organization.
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reasons include change in specialty, permanent emigra-
tion, and temporary emigration of trainees completing
their residency training in the United States, who are
then required to return to their home country for a min-
imum of 2 years owing to immigration rules.
a. Mortality: The mortality rate data for US physi-
cians came from the Census Bureau or physician
associations. The mortality rate for a particular
age-group usually changes little over the years
and can be considered to remain constant over
the forecasting period.
b. Retirement: For some specialties, specific data
are not available from public domain sources.
Specialty-specific surveys can be performed or
information about overall physician levels from
published reports can be used. We surveyed
active pathologists who provided information
on their intended ages of retirement for part-
time and full-time retirement, which we then stra-
tified by respondents’ ages. The planned ages of
retirement proved to differ from the actual ages
of retirement increasingly in the younger decades
as documented by Association of AAMC’s study
and made adjustments accordingly.3
c. Emigration: Many international medical
graduates (IMGs) leave after completing
their residency training, usually due to visa
requirements. ‘‘J’’ visa e´migre´s are eligible
Table 2. Taxonomy and Examples of Pathologist Services.*
One Patient At A Time Individual patients—each item includes all techniques for developing a diagnosis
(eg, light microscopy and in vivo microscopy) and subsequent testing (eg,
molecular, genetic, and immunohistochemistry)
Anatomic pathology (AP) and Surgical Pathology Based on organ and system-based pathology, for example, breast, skin, GI, GU
and gynecologic systems, pulmonary, blood and lymph nodes, etc and includes
tumor board time as pathologist who rendered diagnosis. Institutions variably
classify molecular/genomic pathology as AP or LM
Cytopathology Gynecologic (cervical smears), body cavity fluids, fine needle aspiration (FNA)
Autopsy General and forensic
Laboratory medicine (LM) Microbiology, clinical chemistry, hematology, general laboratory, transfusion
medicine (blood bank)
Genomic pathology Genomic analysis of somatic (cancer) specimens, germline specimens, tissue
human leukocyte antigen (HLA) typing, and infectious disease
Real-time services Pathologist sees patient to perform FNA, bone marrow biopsy, in vivo
microscopy
Provider consults After rendering a diagnosis, time pathologist consults or speaks with clinician to
discuss therapeutic implications, uses EHR for similar purposes, or attends
tumor boards as an interested expert; acute care consultation
Population Services Services groups of patients, communities but not the individual patient
Laboratory medical direction (LMD) Relates to management and operation of laboratories, maintaining quality
standards, policies, certifications, regulatory compliance, CAP inspections.
Outcome assessment/utilization management Determines if tests performed are useful, need upgrading with new or different
methodology, or should be expunged from the test menu offered; quality
assurance studies; engaging other physicians to improve patient outcomes
Biorepository management Oversees patient protection, tissue sample quality, clinical information quality,
bioinformatics and logistics
Public health Includes point-of-care (POC) management of chronic disease; ongoing wellness
management, epidemiology
Clinical informatics Collection, classification, manipulation, storage, retrieval and dissemination of
information to solve problems in pathology in the care of patients
PROFESSIONAL RESPONSIBILITIES To institutions, pathology, including the next generation of pathologists & self
Medical administration (nonoperational) Professional activities associated with institutional committees (executive,
strategic, and library committee) and to managerial and operational aspects of
pathology laboratories on a broad level (eg, personnel and credentialing)
Teaching Relates to residents, medical students, allied health &other physician groups
Research Generally translational research, but includes basic science
Life-long learning activities, including that used to discharge
LMD activities or improve patient care activities.
Maintenance of certification, compliance with federal and state regulations,
journal reading
Professional Societal Obligation Work in CAP committees, advocacy, participation in events, and leadership
Entrepreneurship (Practice management) Running a practice, promoting practice, including client relationship building and
management; developing new models of practice, and potentially disruptive
start-ups/model expansions
Abbreviation: CAP, College of American Pathologists.
*Adapted from Robboy et al.24
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to reapply for return after 2 years abroad, but
the number that returns is uncertain. Other
IMGs leave later on a voluntary basis, seeking
job opportunities elsewhere. Extensive infor-
mation on net emigration is rarely available
due to difficulty in tracking individual candi-
dates and that sourced from the published lit-
erature is of uncertain quality.26 We have
assumed a constant rate of emigration for all
future years.
d. Residents Taking Up Nonmedical Professions:
In addition to residents who change specialties,
some leave the medical profession entirely after
completing their training. The percentage is
sourced from the FREIDA database.27
4. Full-Time Equivalent Conversion: The model uses the
concept of the ‘‘physician FTE’’ which is defined as a
physician working the average number of hours a
full-time physician works. For pathologists, our FTE
calculations compute the count of FTEs of active
pathologists, based on the work hour variations in the
workforce across age-groups and gender. (Note: FTE is
a fixed number but to calculate it requires a count of all
individuals, further refined by assessing each cohort’s
average hours divided by the number of individuals in
the cohort.)
5. Extender Workforce: The extender workforce can be
estimated by identifying the supply of advanced care
practitioners who support a specialty in its work,
adjusted to relative productivity. In case of pathologists,
we focused on estimating the supply of PAs. The key
steps were:
a. Estimating Total Current Pool11: We considered
the total count of active PAs to include those
certified by the American Society of Clinical
Pathology (ASCP) Board of Certification (for-
merly, the ASCP Board of Registry) and those
who are not certified. From our surveys, opi-
nions of team members, and interviews with
executives of the American Association of
Pathology Assistants and others, we found that
the definition of PAs include both certified and
noncertified PAs. We obtained the number of
certified PAs from ASCP. For noncertified PAs,
we estimated the count through an indirect
survey-based approach. We asked pathologists
to provide the number of pathologists and PAs
working in their respective practice settings and
calculated an average industry-level pathologist
to PA ratio, which was prorated to the current
pathologist supply.
b. Conversion of Physician Extender Headcount to
FTE Pathologists: The PAs do not substitute for
pathologists completely but can be viewed as
performing, under supervision, a portion of FTE
work that a pathologist might otherwise
perform, predominantly in autopsy and surgical
pathology gross dissection. For PAs, we esti-
mated relative productivity by conducting a sur-
vey of pathology practice managers asking the
following: (1) number of PAs employed in their
particular setting and (2) number of pathologists
required to replace the work effort performed by
these PAs. From this total, we then calculated
the required replacement factor. Noting that PAs
also perform work that pathologists would not
normally perform, only a portion of the PA
effort counts as equivalent to a portion of
Pathologist FTE.
c. Growth in Physician Extender Numbers: While
both certified and noncertified PA extenders add
to the extender workforce, due to regulatory
changes, we have not projected additions to the
noncertified pool, although some are undoubt-
edly added annually. For the certified work-
force, we used statistics on certified PAs added
annually to the workforce provided by the indus-
try association.
Demand Model Section
In contrast to ‘‘supply,’’ which looks at the numbers of physi-
cians in practice, and how this physician population changes
related to individuals entering and leaving the field, ‘‘demand’’
examines what physicians do, that is, what is requested of them.
Demand looks at how physicians spend their time across ser-
vices types and service locations and anticipates new services
in their infancy and anticipated growth. It allows for testing of
work scenarios with high impact variables and their compari-
son with others.
Compared to supply estimation, demand analysis is much
more complex. Our framework for demand looks at deviations
from an assumed present equilibrium between US physician
supply and per capita physician demand. Forecasting future
demand requires knowledge of many factors, including the
change in overall US population, age and gender mix, mix and
intensity of existing and new services, insurance coverage mix,
change in disease incidence as well as changes in clinical prac-
tice patterns.
In this article, we outline demand principles that apply to all
specialties. When making estimates for a particular physician
specialty, other specialty-specific factors may need to be con-
sidered as well. To understand the detailed methodology used
in estimating the pathologist workforce, please see Robboy
et al.24
 Population mix: The increase in population across age
and gender cohorts directly affects the demand for phy-
sician services. Population projections are available
through the year 2060 across age-groups, gender, and
insurance providers. These projections use US Census
data sets adjusted for net international migration. In this
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manuscript, the numerical value used for each variable
represents what we believe to be the ‘‘most likely’’ net
migration values. This data set is also called ‘‘the middle
value.’’ Sometimes ranges for net migration are given
above or below (high and low values).
 Insurance mix: The different insurance cohorts
(government-sponsored Medicare and Medicaid),
employer-sponsored private insurance, and individually
purchased private insurance consume physician services
differently.24 Our model adjusts for differences in utili-
zation and the projected change in the insurance mix
(provided by the Centers for Medicare and Medicaid
Services).
 Disease incidence: Changes in disease incidence or
degrees of illness can be important drivers of change
in demand for types of physician services. For example,
in the past, the introduction of the polio vaccine elimi-
nated the iron lung specialty. Today, nurse practitioners
and other physician extenders are increasingly managing
chronic care geriatric medicine that physicians largely
performed in prior years.
 Level of services utilized: No published sources expli-
citly stratify how various patient profiles differentially
utilize physician services, but such data can be estimated
through the National Ambulatory Medical Care Survey
and the National Hospital Ambulatory Medical Care
Survey. The samples provide data on patient demo-
graphics, waiting time, medication therapy, procedures,
payment sources, and so on from a national sample of
hospital outpatient departments. To assess pathologist
demand, we chose as our proxy, findings about biopsy
utilization rates and complete blood count (CBC) order-
ing rates.
 Other demands (administrative and other services):
Physicians provide a range of services to patients
directly and indirectly. Some relate more closely to the
service location. The demand for research and teaching
services, for example, largely mirrors the service location
(academicmedical center). The total effort devoted to both
teaching and research relates more to the number of pro-
grams at such centers than to the trainee numbers within
the programs. Based on historical numbers of residency
and fellowship programs in the United States and antici-
pated new program startups, demand can be projected.
Gap Analysis (and Market Force Modules)
New market forces continually emerge that impact demand/
supply beyond the above-mentioned variables. For example,
the advent of genetic analysis of somatic tissues for cancer and
germline testing for heritable conditions is currently expanding
greatly the scope of services pathologists provide. These
include technological development, laboratory performance,
and quality control appropriate to the new services, and diag-
nostic and patient care consultations in the ever-increasing
complexity and scope of genomic pathology. The concept of
genomic medicine as a new area of endeavor extends to many
specialties. As this new field develops, each specialty will need
to determine and better understand how genomic medicine and
other emerging areas will affect their field. Our model allows
such new science and other new technologies to be evaluated
and quantified as to their impact on physician supply and
demand. This article examines genomic pathology and several
other new areas, each in their turn.
Results
Overview
The model permits the user to work in Supply, Demand, Eco-
nomic or Gap Analysis modules, and within each, for example,
supply deeper levels of choice (Figure 1). Each figure is a
screen with which a user interacts in the modeling program.
Supply Model Features
1. Baseline Supply: Physician supply is shown at aggre-
gate levels, with numbers presented both as absolute
headcounts and or recalculated into FTEs (Figure 2).
The FTE count adjusts for physicians working part
time. It also permits the user to make adjustments to
the workforce. For example, the baseline can be further
refined by the percentage of physicians serving as
pathologists who are either practicing as pathologists
but not boarded in pathology or clinicians (eg, hematol-
ogists) who may be board certified in internal medicine
but not in pathology (Figure 3).
2. Segmentation of Supply (Table 2): This section
addresses the important but rarely addressed under-
standing of the multiple services physicians provide in
different locations (eg, hospital, clinic, industry, etc).
Over the course of a career, moreover, many physicians
also take on additional roles beyond their immediate
categorical or subspecialty clinical certification. Com-
monly, these relate to seniority or experience (consul-
tant to junior colleagues), and frequently they are
administrative (committee service). The CAP work-
force team segmented the supply (and therefore
demand) into 16 services across 3 broad categories: One
patient at a time, population services, and professional
responsibilities (Figure 4). Several categories, for
example, anatomic pathology, were further segmented
into multiple subspecialties, for example, breast pathol-
ogy, gastrointestinal pathology, and so on (Figure 5). As
health care evolves, new services will likely emerge that
will require entirely new areas of pathologist expertise,
for example, molecular diagnostics and in vivo micro-
scopy. New services can be added, including defining
their supply (see ‘‘advanced features’’ subsequently).
3. Extender’s Supply: The tab ‘‘Extender’s Supply’’ enu-
merates the supply of advanced clinical practitioners
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who serve as physician extenders (Figure 6) and can
also be segregated by service locations.
4. Supply Scenario Planning and Comparison: When ana-
lyzing physician workforce, some variables invariably
are desired that previously have not been programmed.
Our modeling tool permits creation of new user-defined
scenarios within the supply, demand, and gap analysis
sections. It also permits comparing the effects of differ-
ing variables.
a. Scenario Creation: Involves creating a new sce-
nario or editing an existing one (Figure 7).
b. Scenario Development: Once a new scenario has
been created, a screen specific for the scenario
variables can be updated at will. Underlying
Figure 1. Initial screen overview. The left-hand margin discloses 4 major modules. The upper margin (for choice selected as Supply) displays
subblock Baseline and secondary subblock Development Process. The associated screen discloses the methodology for determining supply.
Figure 2. Pathologists as Headcount and full-time equivalents (FTEs).
8 Academic Pathology
Figure 3. Creating a user-defined baseline, assigning a name, or altering the percentage of nonboarded pathologists or clinicians serving in
pathologist roles.
Figure 4. Distribution of pathologist full-time equivalents (FTEs) into 3 major service areas (1 patient at a time, population services, and
professional responsibilities).
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Figure 5. Distribution of pathologist full-time equivalents (FTEs) in individual subspecialty service areas comprising the overarching category
‘‘One patient at a time.’’
Figure 6. Supply of extender workforce (pathologists’ assistants) with option to segment by service areas and practice locations.
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Figure 7. Creating a new scenario.
Figure 8. Documenting assumptions.
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reasons/rationale can be documented and saved
in the model (Figure 8).
c. Scenario Comparison: Scenarios can be com-
pared at aggregate levels, at service area levels,
and at practice locations levels (Figure 9).
Demand Model Features
1. Baseline Demand: The baseline demand subsection,
which works similarly to the supply section, offers an
overview of physician demand at aggregate levels
(Figure 10), including at the most likely (middle) level
and at high and low ranges.
2. Segmentation of Demand: Segmentation permits viewing
demand of physician services across service areas and
practice locations (Figure 11). In addition, users can create
new services that are likely to be demanded in the future.
This process resembles that outlined under supply.
3. Scenario Planning: This tool allows scenario creation
by permitting values of variables that impact demand to
be altered. Some such variables include disease inci-
dence rates, rates of insurance across population groups
(higher rate of consumption by population cohort with
insurance coverage vs the ones without it), changes in
size of population groups, and their utilization of phy-
sician services (eg, increased demand for obstetrical
services if the population trends toward more females
in child-bearing age). For manageability, the ability to
change some variables was restricted.
Gap Analysis (and Market Force Modules)
Gap analysis allows for comparison of physician supply and
demand and overlay various market forces for numerous vari-
ables. A single screen enables users to both define and compare
demand and supply FTE gaps across 3 dimensions (Figure 12)
including aggregate or service factor or service location level
(dimension 1), across scenarios developed in supply and
demand blocks (dimension 2), across market force modules
(and their in-built scenarios; dimension 3).
Gap Analysis of Service Areas, Adding New Service Areas,
or Changing Mix of Service Areas
Advances in technology and identification of new diseases
continually introduce new services or new ways of performing
Figure 9. Cells changeable to create a new scenario, edit an existing scenario, or compare variables.
12 Academic Pathology
those services. An obvious example in pathology is genomic
medicine, requiring either new skill sets by existing patholo-
gists and/or a new pathologist workforce capable of practicing
in this area. An example in the surgical field, not explored here,
is the introduction of robotic surgery (surgical arms), requiring
surgeons in an increasing number of surgical subspecialties to
add a new skill to adopt this new method of providing their
existing scope of practice. Our model permits users to add
additional new services.
The workforce implication of genomic medicine, as an
example of gap analysis, is explored subsequently in detail,
specifically for performing DNA analysis of tumor specimens.
The field is rapidly changing. This example shows how gene
analysis is rapidly undergoing change as the ‘‘next-generation
sequencing’’ technology advances (from large panel, to exome,
to genome analyses). We describe the impact this has on the
physician effort as the testing transitions from the research
laboratory (circa 2010) into accepted daily clinical use.
The analytic steps required to track the process were:
a. algorithm (Figure 13) and methodology (Figure 14)
preparation when adding a new service13;
b. initiate addition of new service in the segmentation
section of supply/demand model;
c. complete new screen prompts for name of service
with short textual description of service (done via
supply module; Figure 15);
d. replace default assigned null values with appropriate
estimates (use ‘‘Distribute Supply’’ functionality,
see Figure 16) because the new service may also
reduce or replace other services; and
e. assign the overall share of the physician time (%) to a
new service (Figure 17).
Economics. The economics section has particular policy implica-
tions. The data on average payments for various physician services
when coupled with the supply and demand FTEs data from the
other 2 blocks of the tool afford a powerful assessment of the total
value of services thatwill be demanded. It also showshowmuchof
that valuation the physician specialty may garner and also what
portion will not be realized should the supply be lacking.
Note on user tools. We have built several tools for both user and
administrator use, including (1) version log (of any changes in
structure or assumptions of analysis); (2) help tool; (3) metho-
dology tool to understand how a particular demand was calcu-
lated; and (4) a PDF feature to download the current screen on a
user’s desktop.
Discussion
Prediction is difficult, especially when it’s about the future, as
attributed to such diverse persons as the New York Yankee
Figure 10. Baseline demand, overall, which can be segmented by high- to low-level aggregates of service lines.
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Figure 11. Demand, presegmented by high-level groupings service lines, further segmented by more detailed service lines.
Figure 12. Three dimensions of data selection for gap analysis, using overall supply and demand as an example.
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baseball player and manager, Yogi Berra, and Nobel prize
physicist, Niels Bohr. Prediction about the physician workforce
is no exception. Modeling tools are helpful in examining the
current status, the availability of goods or manpower, and the
demands placed upon the system, in turn permitting projections
by asking what would happen as conditions change.
In an ambitious program begun by the CAP (or College)
nearly 5 years ago, we sought to develop an in-depth
understanding of the current workforce and practice modes,
identify new and emerging market forces (political, eco-
nomic, commercial, and technology related), and ascertain
and measure the impact these forces might have on pathol-
ogy practice models and workforce. The goal was to iden-
tify existing and new services as well as emerging
technologies where pathologists might play critical roles
in the future.
Figure 13. Algorithm for genomic analysis of tissues, usually for cancer.
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Figure 14. Methodology to perform genomic analysis of tissue specimens, usually for cancer.
16 Academic Pathology
We used this to examine both the supply11 and the demand24
trajectories of the pathologist workforce through the year 2030.
This manuscript presents the details of the modeling methodol-
ogy and makes the modeling process available to a broader
group of stakeholders in the medical industry.
Strengths
Our modeling tool, while specific for the discipline of pathol-
ogy, was built to be generalizable to any specialty in medicine
with only minor modifications. From a high-level point of
view, our focus was on a user such as a medical organization
trying to determine its specialty’s future rather than on a public
policy assessment of health care needs for the nation as a
whole. The model also partially incorporates data about asso-
ciated physician extenders (in our case, pathologists’ assis-
tants) and close associates (such as clinical PhDs who are
key in some laboratory operations, and nonpathologist physi-
cians who may direct some subspecialty clinical laboratories).
Besides other named specialties, we envisaged that this model
could assess service lines crossing practices. An example is
oncology, where different specialties and professionals work
as an integrated clinical service (oncologist, surgeon or nurse
practitioner who see the patients, specialists such as the radi-
ologist, pathologist, or radiation therapist), and all provider
groups can be included.
This model, by encouraging pathology to develop a robust
taxonomy, describes broadly and at a granular level what these
providers do and where. Thus, pathologists deliver direct
patient care (diagnostic ‘‘one patient at a time’’), supervise
quality laboratory testing for patient populations (laboratory
medical direction—‘‘population services’’), and engage in
other professional services (research, teaching, and medical
administration—‘‘professional responsibilities’’). The model
details where the work is done, for example, in an academic
medical center, or multiple types of hospitals, specialized facil-
ities, or core facilities spanning multiple institutions. By
broadly framing an all-encompassing taxonomy, refinements
can be introduced easily, as new meaningful data become avail-
able. As the emerging trend today is for pathologists to practice
as subspecialists, our model can easily be refined to enumerate
the many smaller groupings not currently specified. Anatomic
pathology, for which we have data and forecasts for the major
subspecialties, can be expanded readily to include the numer-
ous smaller subspecialties. Laboratory medicine, also, can be
further segmented by work areas to allow analysis of chemis-
try, microbiology, genomic medicine, and blood bank and
transfusion medicine, and so on. Any other specialty wishing
to employ our model would first need to develop its own
specialty-specific detailed taxonomy.
Over time, every job function may become archaic. Ideally,
all specialties should render archaic activities obsolete, before
Figure 15. Adding new service and providing basic details (name, category, etc).
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someone else does. Any modeling tool required the capability
to record and even forecast such change, such as what our
model has done to identify the manpower needs for the emer-
ging practice area of genomic medicine. Through a detailed but
flexible taxonomy and gap analysis functionality, the impact of
new as well as fading areas can be measured and indeed fore-
cast, which is certainly useful for planning fellowship programs
and future practitioner numbers.
The model has been built so that parameters can be evalu-
ated at settings with 3 levels of likelihood (high, low, and
middle) or by values considered the most likely. As demo-
graphic data such as census data, mortality, retirement, and
so on change, the modeling system permits updating of such
external governmental tables without the need for programmer
assistance. Other important features are that gap analyses can
be performed that can forecast differences (‘‘gaps’’) between
the anticipated supply and demand and that entirely new areas
of practice (be it a specialty or new field based on new tech-
nology) can be built into the working model by the end user.
This model allows for testing of assumptions where supply and
especially demand can be assessed across many specific areas.
The model is flexible and allows ‘‘what if’’ queries.
Specifically, the user may manually alter key parameters,
thereby assessing the effects of projected or hypothetical
changes.
A final strength of this work lies in the ability to quanti-
tatively model some effects that may result from changes
coming in American medicine. As one example, we looked
at certain disruptive alterations likely to ensue as conse-
quences, whether desirable or not, of American health care
reform. In pathology, system consolidation is forcing some
smaller laboratories to close or combine. We were able to
model what the effect would be if 1% of laboratories closed
each year, starting in 2014, or if the laboratory medical
direction stayed stable, or increased 1% or 2% biennially
due to new regulations. We also began work to estimate the
impact that introducing molecular human papillomavirus
(HPV) testing and anti-HPV vaccines might have on medi-
cine during the next half decade. Due to the difficulty col-
lecting sufficient data in these nascent areas of endeavor
and the controversies that ensued in interpreting the data
we did collect, these types of efforts never made it to the
final model. We believe that future versions of our model
will further explore these areas.
Figure 16. Assigning pathologist time involved in each of types of analytic tests (large panel analysis, exome analysis, and genome analysis for
each of year when technology is rapidly changing). Seven key variables need scoring for realistic forecasts.
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Limitations
The very process of identifying so many variables in a model-
ing tool reveals potential shortcomings, and this project was no
exception. Currently, the data for our model is national in
scope. We have not attempted modeling at the state level. The
model also inadequately accounts for the pathology services
performed by nonpathologist physicians. For example, some
dermatologists whom the American Board of Pathology has
certified to practice dermatopathology split their efforts
between their pathology and clinical services. This is true also
for some internists, especially hematologists, only some of
whom are coboarded by the American Board of Pathology.
Our work also points up the inadequately reliable public
data about pathologists, which is likely true for many other
specialties constituting the House of Medicine. Most data about
pathologists currently comes from group practices typical of
universities or private practices, whether large and small. How-
ever, data to analyze efforts by service location are inadequate.
We have limited data about pathologist supply and demand for
independent commercial labs and little data about pathologist
activities in research organizations or the biopharmaceutical
industry. In addition, for some variables, we have estimated
that physician work effort will change little in the coming
years, for example, transfusion medicine but may be in error
in assuming that past evidence of stability translates into future
stability in such variables. This will be true for any specialty
performing workforce modeling.28
Our study lacked a detailed database, either qualitative or
quantitative, on where tests were actually performed (service
location). For example, great variability exists in community
hospitals as to what percentage of laboratory medicine testing
is performed inhouse and what is performed in an outside ref-
erence or commercial laboratory. And in each instance, how
does the effort of the pathologists within the hospital segregate
to oversight of performance, laboratory medical direction,
working with other clinicians, and providing direct services
to patients. So while we could model the overall trajectory of
the pathologist workforce supply and demand, there was little
insight into how changes in demand might later affect where
and how pathologists might be practicing.
There is value to determine how reducing the cost of health
care might affect provider demand. To do so, we must antici-
pate the innovations and disruptions that will drive reducing
costs, such as by shifting some of today’s physician tasks to
nonphysician staff25 or shifting greater amounts of health care
to the ambulatory setting. To do so in pathology, we need better
to integrate what physician assistants and nonphysician doc-
toral scientists do. For example in pathology, some PA effort
substitutes directly for pathologist effort but much does not.
Without PAs, certain services would likely go undone, for
example, tissue preparation for biorepository use and specimen
Figure 17. Assigning overall share of physician time (%) to a new service.
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photography. We are uncertain how PA efforts differ quantita-
tively between academic medical centers and community hos-
pitals, for example, in grossing specimens for subsequent
microscopic examination, which limits our understanding of
the potential PA role if the anticipated decrease in pathologist
numbers materializes. Both PAs and nonphysician doctoral
scientists bring distinct skills that need integration into a more
holistic view of laboratory workforce demand. We anticipate
analogous issues across all specialties. Clearly, as more com-
prehensive data are collected about pathology assistants and
PhD clinical scientists, their efforts will be integrated more
fully into future pathology workforce analyses.
Final limitations in this first software version are technical
in nature. Our modeling tool is available only offline, although
multiple users can access it through a shared network. Also,
this modeling version supports the addition of a maximum of
up to six new services, although this could readily be increased.
Summary
We have developed and described the functions of a model and
the software to drive it which permits analysis of pathologist
activities, both for supply and for demand. The model was
developed with generalized concepts that would, with little
tweaking, be applicable to any medical specialty. The function-
ality and output of the model, which has been reported else-
where,11,24 supports analysis of the anticipated future supply of
pathologists through 2030 and types of demand that the pathol-
ogist workforce will likely experience. The software model
supports quantitative forecasting for both current and new areas
of effort. This model can test hypotheses and examine impli-
cations for pathologist workforce requirements, including
financial consequences. In developing the model, we also
developed a new taxonomy for the practice of pathology, which
includes work done for populations as a whole as well as for
individual patients one at a time and thus differs from the
taxonomies of other clinical specialties.
Medicine in general, and not just pathology, is experiencing
unprecedented change at this time. We foresee that emerging
technologies will drastically alter the laboratory and other areas
in medicine (eg, nanotechnology, telemedicine, remote diag-
nostics, and team care throughout patients’ lives with real-time
capture of patient data) in sickness or health, regardless of
location. New technologies employed today, such as genomic
medicine and clinical informatics, represent significant oppor-
tunities for pathologists. We foresee the changing delivery of
health care will motivate all physicians to provide and ensure
the highest quality of diagnostic testing and accurate reporting
of clinical information to improve outcomes and maximize
patient safety. The corresponding challenge we foresee will
be to develop and apply modeling tools that integrate and eval-
uate demand across disciplines. Such tools will more accu-
rately determine the numbers of physicians and others in the
health care team required to efficiently and effectively care for
patients and populations of patients in providing correct
diagnosis, chronic disease prevention and management, and
optimal treatment decisions.
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